For GBM, common driver and tumour-suppressor genetic alterations include phosphoinisitide 3-kinase (PI3K) mutations for uncontrolled signalling, driving the continual activation of protein kinase B/Akt and leading to high rates of glucose import (58). Here, AKT1 is linked to neoplasm.